Your browser is no longer supported. Please, upgrade your browser.
Settings
BSX Boston Scientific Corporation daily Stock Chart
BSX [NYSE]
Boston Scientific Corporation
IndexS&P 500 P/E- EPS (ttm)-0.26 Insider Own0.40% Shs Outstand1.36B Perf Week0.08%
Market Cap32.32B Forward P/E18.86 EPS next Y1.26 Insider Trans-15.41% Shs Float1.35B Perf Month-2.26%
Income-345.00M PEG- EPS next Q0.27 Inst Own94.10% Short Float1.22% Perf Quarter3.13%
Sales7.96B P/S4.06 EPS this Y-98.30% Inst Trans-1.02% Short Ratio2.00 Perf Half Y26.26%
Book/sh4.58 P/B5.19 EPS next Y14.35% ROA-1.90% Target Price- Perf Year48.44%
Cash/sh0.32 P/C73.78 EPS next 5Y12.75% ROE-5.40% 52W Range15.67 - 24.79 Perf YTD28.80%
Dividend- P/FCF45.07 EPS past 5Y24.00% ROI0.70% 52W High-5.53% Beta0.90
Dividend %- Quick Ratio0.70 Sales past 5Y-0.90% Gross Margin71.10% 52W Low49.46% ATR0.39
Employees25000 Current Ratio1.00 Sales Q/Q15.40% Oper. Margin-7.70% RSI (14)42.57 Volatility1.35% 1.71%
OptionableYes Debt/Eq0.87 EPS Q/Q-303.60% Profit Margin-4.30% Rel Volume0.76 Prev Close23.75
ShortableYes LT Debt/Eq0.83 EarningsOct 27 BMO Payout- Avg Volume8.20M Price23.42
Recom1.90 SMA20-1.51% SMA50-2.09% SMA20012.13% Volume3,157,444 Change-1.39%
Sep-01-16Upgrade Argus Hold → Buy
Jul-29-16Reiterated Wedbush Neutral $23 → $25
Jul-29-16Reiterated Needham Buy $26 → $28
Jul-28-16Reiterated The Benchmark Company Buy $25 → $31
Jun-09-16Initiated Guggenheim Buy
Apr-28-16Reiterated Wedbush Neutral $19 → $23
Apr-28-16Reiterated Stifel Buy $22 → $25
Apr-28-16Reiterated RBC Capital Mkts Outperform $22 → $25
Apr-28-16Reiterated Barclays Overweight $23 → $25
Apr-27-16Reiterated The Benchmark Company Buy $20 → $22
Apr-12-16Reiterated RBC Capital Mkts Outperform $20 → $22
Mar-17-16Initiated Nomura Buy
Feb-25-16Initiated Sun Trust Rbsn Humphrey Buy $21
Nov-12-15Initiated Citigroup Buy
Oct-28-15Reiterated Needham Buy $21 → $22
Oct-05-15Upgrade Raymond James Outperform → Strong Buy
Sep-28-15Upgrade Needham Hold → Buy $21
Aug-27-15Upgrade Goldman Neutral → Buy
Jul-23-15Reiterated The Benchmark Company Buy $19 → $20
May-04-15Reiterated Deutsche Bank Hold $17 → $19
Sep-29-16 11:04AM  Most Analysts Rate Boston Scientific a Buy
10:05AM  What Is Boston Scientifics Latest Valuation?
10:03AM  7 Healthcare Stocks in Focus on World Heart Day
08:05AM  FDA Approves Boston Scientifics Emblem MRI S-ICD System
Sep-28-16 04:04PM  Boston Scientifics Lotus Edge Valve System Gets Approval in Europe
02:04PM  Boston Scientifics Acquisition of EndoChoice: Must-Know Details
12:29PM  How Has Boston Scientifics Stock Performed Recently?
09:16AM  Blog Coverage Boston Scientific Announces Acquisition of EndoChoice in a Strategic Endoscopic Merger
Sep-27-16 10:52AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of EndoChoice Holdings, Inc. to Boston Scientific Corporation for $8.00 Per Share is Fair to Shareholders -- GI Accesswire
10:27AM  U.S. stocks turn higher in wake of Clinton-Trump debate at MarketWatch
09:54AM  ETFs with exposure to Boston Scientific Corp. : September 27, 2016
09:13AM  EndoChoice (GI) Alert: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of EndoChoice Holdings, Inc.; Is $8.00 a Fair Price? PR Newswire
09:01AM  [video]EndoChoice (GI) Stock Soars on Boston Scientific Deal
08:19AM  Early movers: TWTR, VLKAY, AXP, SJM, AZO & more at CNBC
07:31AM  [$$] Boston Scientific to Buy EndoChoice at The Wall Street Journal
06:54AM  Boston Scientific to Buy Endoscopy Company in $210M Deal at Bloomberg
06:45AM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:30AM  Boston Scientific to Acquire EndoChoice PR Newswire
Sep-21-16 11:55AM  Amazon (AMZN), Charter Communications (CHTR) And 3 Other Hot Stocks That Billionaire Ken Griffin Is Bullish On at Insider Monkey
Sep-20-16 10:53AM  Boston Scientific's LOTUS Edge Valve System Gets CE Mark
Sep-19-16 10:04AM  Discussing St. Jude Medicals Latest Valuation
02:00AM  Boston Scientific Receives CE Mark For LOTUS Edge Valve System PR Newswire
Sep-14-16 07:01PM  Cramer: This Is a Market of Stocks, not a Market of Markets
06:54PM  Cramer: A dangerous market for hedge funds is an innovative one for you at CNBC
06:00AM  Jim Cramer's Top Takeaways: Wells Fargo, Boston Scientific
Sep-13-16 07:54PM  Cramer Remix: Mixed messages from the Fed are hurting the market at CNBC
11:22AM  Boston Scientific Corp. Value Analysis (NYSE:BSX) : September 13, 2016
09:47AM  Boston Scientific calls buy time for rally
Sep-12-16 08:47AM  Boston Scientific Corp. breached its 50 day moving average in a Bearish Manner : BSX-US : September 12, 2016
Sep-09-16 06:04PM  New Long-Term Data Reaffirm the Benefits of Medtronics Micra TPS
Sep-07-16 09:06AM  Why Boston Scientific Keeps Rising
Sep-06-16 07:42AM  These 5 Rocket Stocks Look Ready for Blastoff
Sep-01-16 11:40AM  Why Boston Scientific Shares Could Rise Almost 40% More as Turnaround Continues at 24/7 Wall St.
10:27AM  Argus Upgrades Boston Scientific, Sees Market Share Gains And Strong Growth Ahead
10:04AM  What Analysts Recommend for Medtronic after 1Q17 Earnings
08:55AM  Top Analyst Upgrades and Downgrades: Boston Scientific, Micron Tech, Salesforce.com, TransCanada, Walgreens and More at 24/7 Wall St.
08:05AM  EW Poised to Carve Out More Prosthetic Heart Valve Market Share
08:04AM  A Look at How C.R. Bards Valuation Compares to Its Peers
08:04AM  Medtronics Latest Valuation: Heres What You Need to Know
07:42AM  Boston Scientific upgraded by Argus
Aug-31-16 05:04PM  Edwards Lifesciences Capitalizes on Valve Replacement Market
04:04PM  Analyzing C.R. Bards Strong Product Pipeline
03:04PM  What Caused Edwards Lifesciences to Guide Higher?
12:34PM  Analysts Recommendations for C.R. Bard in 2016
08:08AM  Boston Scientific's Innovation & Emerging Market Raise Hope
08:05AM  Johnson & Johnsons Medical Devices Segment
Aug-30-16 08:30AM  Boston Scientific To Participate In Morgan Stanley Global Healthcare Conference PR Newswire
Aug-29-16 04:07PM  Medtronic Registers In-Line Earnings, Missed Revenue Estimates
11:08AM  ETFs with exposure to Boston Scientific Corp. : August 29, 2016
Aug-27-16 12:50AM  Huge Jumps In Hedge Fund Popularity For These 5 Healthcare Stocks at Insider Monkey
Aug-26-16 10:22AM  Traders turn bullish on Boston Scientific
08:03AM  Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : August 26, 2016
Aug-25-16 04:55PM  Medtronic Misses High Expectations; St. Jude Dives On Hacking Claim
Aug-24-16 08:41AM  Medtronic Earnings Face FX Headwinds, But Cardiac Trends Good
08:30AM  Boston Scientific To Participate In Wells Fargo 2016 Healthcare Conference PR Newswire
Aug-23-16 09:04AM  Analysts Latest Recommendations for Boston Scientific
Aug-22-16 11:04AM  Delving into BSXs Category Leadership Growth Strategy
09:30AM  Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scientific and Priceline Group
09:05AM  Whats BSXs Capital Allocation Strategy Going Forward?
07:52AM  Edwards Lifesciences Is Taking The Surgery Out Of Heart Surgery
06:21AM  Analyzing Medtronics Valuation before Its 1Q17 Results
Aug-19-16 11:05AM  Discussing Boston Scientifics Expanding Operating Margins
09:05AM  Whats Driving Boston Scientifics Rhythm Management Segment?
08:05AM  5 Top ROE Stocks to Play in an Aging Bull Market
Aug-18-16 04:30PM  How BSX Plans to Accelerate Its Neuromodulation Market Position
04:30PM  A Look at Boston Scientifics Latest Valuation
Aug-15-16 10:00AM  FDA Approves Boston Scientific's Emblem MRI S-ICD System
Aug-10-16 01:04PM  BOSTON SCIENTIFIC CORP Financials
11:04AM  What Analysts Recommend for Becton Dickinson after 3Q16 Earnings
Aug-09-16 11:06AM  Becton Dickinsons BD Life Sciences in Fiscal 3Q16: Strong Growth
09:06AM  Becton Dickinsons BD Medical Segment Sales in Fiscal 3Q16
07:41AM  Boston Scientific Adds EMBLEM MRI S-ICD System To Its Growing ImageReady MR-Conditional Devices
07:00AM  Boston Scientific Announces U.S. FDA Approval Of EMBLEM MRI S-ICD System PR Newswire
12:09AM  [$$] Medicare Requires Some Heart Patients to See a Second Doctor at The Wall Street Journal
Aug-08-16 09:57AM  Becton Dickinson Beat Fiscal 3Q16 Earnings Estimates
Aug-04-16 02:43PM  ETFs with exposure to Boston Scientific Corp. : August 4, 2016
09:30AM  Zacks.com featured highlights: Macy's, General Mills, Zoetis, Boston Scientific and Citrix Systems
Aug-03-16 04:15PM  BOSTON SCIENTIFIC CORP Files SEC form 10-Q, Quarterly Report
08:57AM  5 Top ROE Stocks to Buy as Earnings Growth Remains Elusive
Aug-02-16 05:58PM  Vanguard Sold Shares in 7 of Top 10 Quarterly Transactions
11:56AM  Boston Scientific Corp. :BSX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016
11:04AM  Analysts Recommendations for C.R. Bard after Its 2Q Earnings Post
Aug-01-16 11:06AM  What Analysts Recommend for Boston Scientific after Q2
09:09AM  Boston Scientifics Updated Guidance for 2016
08:30AM  Boston Scientific To Participate In Canaccord Genuity Growth Conference And Wedbush PacGrow Healthcare Conference PR Newswire
Jul-31-16 10:10AM  Analysts See Boston Scientific Turnaround Continuing to Run at 24/7 Wall St.
Jul-29-16 01:25PM  Boston Scientific (BSX) Stock Price Target Raised at Jefferies
12:58PM  Boston Scientifics Stock Surged after 2Q16 Earnings
12:58PM  Boston Scientifics 2Q16 Earnings Beat Analyst Estimates
11:17AM  C.R. Bards Vascular Segment Flowing Well despite Tougher Comps
11:17AM  C.R. Bard Registered Strong 2Q16 Performance, Beat Estimates
09:16AM  Boston Scientific Sticks to Solo Strategy as Peers Consolidate at Bloomberg
Jul-28-16 04:19PM  BOSTON SCIENTIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
03:03PM  Boston Scientific (BSX) Meets Q2 Earnings Estimate, Views Up
01:37PM  Boston Scientific posts strong sales and boosts its outlook
12:37PM  3 Top-Rated Medical Device Stocks Beating Q2 Estimates
11:25AM  Boston Scientific raises full-year sales estimates again at bizjournals.com
11:15AM  Boston Scientific buys pain-management business, boosts its outlook at bizjournals.com
10:10AM  Boston Scientific (BSX) Stock Rises After Q2 Revenue Beat
08:19AM  Boston Scientific (BSX) Posts In-Line Q2 Earnings, View Up
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pratt Timothy A.EVP, GC & Chief Admin OfficerSep 01Option Exercise13.5617,000230,520280,495Sep 06 04:08 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerSep 01Sale24.1024,074580,073256,421Sep 06 04:08 PM
Sorenson John BradleySVP, Manuf & Sup ChnAug 11Sale23.902,50059,75012,615Aug 15 07:43 AM
Pratt Timothy A.EVP, GC & Chief Admin OfficerAug 01Option Exercise13.5617,000230,520287,495Aug 02 04:10 PM
Mahoney Michael FPresident & CEOAug 01Sale24.4444,4001,084,9941,388,177Aug 02 04:12 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerAug 01Sale24.4624,000586,956263,495Aug 02 04:10 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJul 20Option Exercise6.3178,122492,950125,092Jul 21 04:05 PM
Phalen Michael P.EVP & President, MedSurgJul 20Option Exercise12.5235,000438,200124,309Jul 20 04:29 PM
Pierce David ASVP and President, EndoscopyJul 20Option Exercise10.702,48026,53628,080Jul 20 04:30 PM
Pierce David ASVP and President, EndoscopyJul 20Sale24.032,48059,59425,600Jul 20 04:30 PM
Phalen Michael P.EVP & President, MedSurgJul 20Sale24.0335,000841,05089,309Jul 20 04:29 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJul 20Sale24.0378,1221,877,27246,970Jul 21 04:05 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJul 01Option Exercise13.5617,000230,520294,495Jul 05 04:09 PM
Mahoney Michael FPresident & CEOJul 01Sale23.43100,0002,342,5701,432,577Jul 05 04:09 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJul 01Sale23.3924,000561,425270,495Jul 05 04:09 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJun 01Option Exercise13.5617,000230,520301,724Jun 03 07:58 AM
Mahoney Michael FPresident & CEOJun 01Sale22.69100,0002,268,6501,532,577Jun 03 07:57 AM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJun 01Sale22.6624,229548,976277,495Jun 03 07:58 AM
Sorenson John BradleySVP, Manuf & Sup ChnMay 11Sale22.152,80062,02015,115May 12 04:07 PM
Dawkins Keith DEVP, Global Chief Med. Off.May 10Sale22.1580,0001,772,224150,227May 12 04:06 PM
Fitzgerald Joseph MichaelEVP & President, CRMMay 03Sale21.8179,9601,743,53692,020May 04 04:26 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMay 02Option Exercise13.5617,000230,520308,724May 03 04:11 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMay 02Sale21.9324,000526,438284,724May 03 04:11 PM
Mahoney Michael FPresident & CEOMay 02Sale22.12100,0002,212,2701,632,577May 03 04:12 PM
Ballinger Kevin J.SVP & Pres, Interven CardioApr 27Option Exercise9.09111,8071,015,979158,777Apr 28 04:22 PM
Pierce David ASVP and President, EndoscopyApr 27Option Exercise8.3016,512137,05042,112Apr 28 04:26 PM
Phalen Michael P.EVP & President, MedSurgApr 27Option Exercise12.5235,000438,200124,309Apr 28 04:33 PM
Pierce David ASVP and President, EndoscopyApr 27Sale21.6916,512358,16225,600Apr 28 04:26 PM
Phalen Michael P.EVP & President, MedSurgApr 27Sale22.0035,000770,00089,309Apr 28 04:33 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 27Sale21.4039,927854,438291,724Apr 28 04:29 PM
Ballinger Kevin J.SVP & Pres, Interven CardioApr 27Sale21.62111,8072,416,77546,970Apr 28 04:22 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventApr 04Sale19.0018,422350,01896,634Apr 05 04:33 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 01Option Exercise13.5617,000230,520355,651Apr 05 04:35 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerApr 01Sale18.7324,000449,462331,651Apr 05 04:35 PM
Ballinger Kevin J.SVP & Pres, Interven CardioMar 11Sale18.0016,705300,69046,970Mar 14 04:10 PM
Pierce David ASVP and President, EndoscopyMar 08Sale17.2751,763894,18525,600Mar 08 04:16 PM
Prange KarenSVP&Pres, Uro & Pelvic HealthMar 08Sale17.2714,747254,74938,395Mar 08 04:13 PM
Mackey Edward FEVP, OperationsMar 02Option Exercise0.0019,226020,655Mar 03 04:11 PM
Phalen Michael P.EVP & President, MedSurgMar 02Sale17.1710,665183,10389,309Mar 02 04:10 PM
Mahoney Michael FPresident & CEOMar 01Sale16.96100,0001,695,6001,832,577Mar 02 04:07 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerMar 01Sale16.9715,068255,755338,651Mar 02 04:13 PM
Phalen Michael P.EVP & President, MedSurgFeb 29Sale17.191,81931,27299,974Mar 01 04:32 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 29Sale17.172,11436,29763,675Mar 01 04:17 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 28Option Exercise0.0011,338071,254Mar 01 04:17 PM
Pierce David ASVP and President, EndoscopyFeb 28Option Exercise0.007,890081,080Mar 01 04:35 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 28Option Exercise0.009,5810176,599Mar 01 04:27 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 28Option Exercise0.008,555020,790Mar 01 04:38 PM
Bose SupratimEVP & President, Asia-PacificFeb 28Option Exercise0.006,7660248,053Mar 01 04:19 PM
Brennan Daniel J.EVP and CFOFeb 28Option Exercise0.005,4980155,896Mar 01 04:22 PM
Carruthers WendySVP, Human ResourcesFeb 28Option Exercise0.006,513092,783Mar 01 04:22 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 28Option Exercise0.007,9110118,870Mar 01 04:27 PM
Phalen Michael P.EVP & President, MedSurgFeb 28Option Exercise0.0013,7940108,291Mar 01 04:32 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 28Option Exercise0.005,6530177,689Mar 01 04:32 PM
Mahoney Michael FPresident & CEOFeb 28Option Exercise0.0050,74401,956,478Mar 01 04:27 PM
Mahoney Michael FPresident & CEOFeb 27Option Exercise0.0057,32501,932,735Mar 01 04:27 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 27Option Exercise0.002,3890173,099Mar 01 04:32 PM
Phalen Michael P.EVP & President, MedSurgFeb 27Option Exercise0.006,370097,498Mar 01 04:32 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventFeb 27Option Exercise0.002,3890112,111Mar 01 04:27 PM
Carruthers WendySVP, Human ResourcesFeb 27Option Exercise0.004,618088,446Mar 01 04:22 PM
Brennan Daniel J.EVP and CFOFeb 27Option Exercise0.002,5880151,617Mar 01 04:22 PM
Bose SupratimEVP & President, Asia-PacificFeb 27Option Exercise0.003,1850241,287Mar 01 04:19 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 27Option Exercise0.007,166014,641Mar 01 04:38 PM
Fitzgerald Joseph MichaelEVP & President, CRMFeb 27Option Exercise0.005,9720169,897Mar 01 04:27 PM
Pierce David ASVP and President, EndoscopyFeb 27Option Exercise0.003,185074,691Mar 01 04:35 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 27Option Exercise0.003,185061,452Mar 01 04:17 PM
Brennan Daniel J.EVP and CFOFeb 25Sale17.483,62063,278149,029Feb 26 04:29 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 25Sale17.481,90333,26458,267Feb 26 04:21 PM
Bose SupratimEVP & President, Asia-PacificFeb 24Option Exercise0.002,6760238,102Feb 26 04:26 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 24Option Exercise0.002,867061,552Feb 26 04:21 PM
Carruthers WendySVP, Human ResourcesFeb 24Option Exercise0.002,484084,998Feb 26 04:30 PM
Brennan Daniel J.EVP and CFOFeb 24Option Exercise7.2392,496668,555254,941Feb 26 04:29 PM
Brennan Daniel J.EVP and CFOFeb 24Sale17.2199,5911,713,961152,649Feb 26 04:29 PM
Sorenson John BradleySVP, Manuf & Sup ChnFeb 23Option Exercise0.001,53207,137Feb 25 04:36 PM
Thepaut Eric Francis YvesSVP & Pres, EuropeFeb 23Option Exercise0.009190105,257Feb 25 04:37 PM
Prange KarenSVP&Pres, Uro & Pelvic HealthFeb 23Option Exercise0.002,299051,064Feb 25 04:34 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerFeb 23Option Exercise0.003,6780353,954Feb 25 04:34 PM
Nanavaty MaulikSVP & Pres, NeuromodulationFeb 23Option Exercise0.001,8390169,732Feb 25 04:28 PM
Phalen Michael P.EVP & President, MedSurgFeb 23Option Exercise0.002,4520124,570Feb 25 04:29 PM
Pierce David ASVP and President, EndoscopyFeb 23Option Exercise0.002,452071,044Feb 25 04:30 PM
Bose SupratimEVP & President, Asia-PacificFeb 23Option Exercise0.002,1450235,426Feb 25 04:13 PM
Brennan Daniel J.EVP and CFOFeb 23Option Exercise0.005,3640164,189Feb 25 04:17 PM
Carruthers WendySVP, Human ResourcesFeb 23Option Exercise0.002,452083,587Feb 25 04:17 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 23Option Exercise0.003,678060,458Feb 25 04:13 PM
Ballinger Kevin J.SVP & Pres, Interven CardioFeb 17Sale17.377,616132,29023,080Feb 18 04:16 PM
Dockendorff Charles JDirectorFeb 12Buy16.4930,000494,68841,598Feb 16 04:07 PM
Prange KarenSVP&Pres, Uro & Pelvic HealthFeb 08Sale16.056,21699,78523,647Feb 09 04:06 PM
Phalen Michael P.EVP & President, MedSurgJan 08Sale17.6718,221322,04588,971Jan 11 08:53 AM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 08Sale17.677,160126,549303,776Jan 11 08:53 AM
Ballinger Kevin J.SVP & Pres, Interven CardioJan 07Sale17.7319,059337,82630,323Jan 07 04:42 PM
Ballinger Kevin J.SVP & Pres, Interven CardioJan 05Sale18.0016,114290,05249,382Jan 06 04:14 PM
Bose SupratimEVP & President, Asia-PacificJan 03Option Exercise0.0014,9260165,623Jan 05 04:11 PM
Pratt Timothy A.EVP, GC & Chief Admin OfficerJan 01Option Exercise0.0042,8780325,173Jan 05 04:11 PM
Prange KarenSVP&Pres, Uro & Pelvic HealthJan 01Option Exercise0.0018,866036,296Jan 05 04:11 PM
Pierce David ASVP and President, EndoscopyJan 01Option Exercise0.0022,296047,896Jan 05 04:11 PM
Phalen Michael P.EVP & President, MedSurgJan 01Option Exercise0.0027,4410116,412Jan 05 04:11 PM
Nanavaty MaulikSVP & Pres, NeuromodulationJan 01Option Exercise0.0017,1500153,575Jan 05 04:11 PM
Mirviss Jeffrey B.SVP&Pres, Periph InterventJan 01Option Exercise0.0018,866099,128Jan 05 04:11 PM
Mahoney Michael FPresident & CEOJan 01Option Exercise0.00257,27301,692,598Jan 05 04:11 PM
Fitzgerald Joseph MichaelEVP & President, CRMJan 01Option Exercise0.0030,8720134,797Jan 05 04:11 PM
Dawkins Keith DEVP, Global Chief Med. Off.Jan 01Option Exercise0.0024,0110204,794Jan 05 04:11 PM